中泛控股(00715.HK):正評估仲裁程序對集團法律、財務及經營影響
中泛控股(00715.HK)公布,公司接獲總承包商通知,總承包商已依照美國仲裁協會的「快速通道」規則,要求根據母公司擔保在加利福尼亞州洛杉磯與公司進行仲裁,涉及3,844萬美元(相當於約2.98億港元)的款項、利息及仲裁成本。
公司指,現正評估仲裁程序對集團而言的法律、財務和經營影響,尤其是往後對公司採取的法律行動對公司及集團而言的潛在影響。公司已聘請律師就仲裁進行抗辯,並會與美國及香港的代表律師緊密合作。從仲裁的申索金額與集團資產淨值相比來看,仲裁對集團的影響不大,惟仲裁裁決對集團的後續財務影響尚未確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.